| Breast cancer risk genes—association analysis in more than 113,000 women Breast Cancer Association Consortium New England Journal of Medicine 384 (5), 428-439, 2021 | 767 | 2021 |
| Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674-685, 2020 | 411 | 2020 |
| Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis MB Mukesh, GC Barnett, JS Wilkinson, AM Moody, C Wilson, L Dorling, ... Journal of clinical oncology 31 (36), 4488-4495, 2013 | 254 | 2013 |
| A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity GC Barnett, D Thompson, L Fachal, S Kerns, C Talbot, RM Elliott, ... Radiotherapy and Oncology 111 (2), 178-185, 2014 | 184 | 2014 |
| A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24. 1 L Fachal, A Gomez-Caamano, GC Barnett, P Peleteiro, AM Carballo, ... Nature genetics 46 (8), 891-894, 2014 | 169 | 2014 |
| Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients CN Andreassen, BS Rosenstein, SL Kerns, H Ostrer, D De Ruysscher, ... Radiotherapy and Oncology 121 (3), 431-439, 2016 | 130 | 2016 |
| Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel JE Abraham, Q Guo, L Dorling, J Tyrer, S Ingle, R Hardy, AL Vallier, ... Clinical Cancer Research 20 (9), 2466-2475, 2014 | 123 | 2014 |
| Radiogenomics consortium genome-wide association study meta-analysis of late toxicity after prostate cancer radiotherapy SL Kerns, L Fachal, L Dorling, GC Barnett, A Baran, DR Peterson, ... JNCI: Journal of the National Cancer Institute 112 (2), 179-190, 2020 | 97 | 2020 |
| Meta-analysis of genome wide association studies identifies genetic markers of late toxicity following radiotherapy for prostate cancer SL Kerns, L Dorling, L Fachal, S Bentzen, PDP Pharoah, DR Barnes, ... EBioMedicine 10, 150-163, 2016 | 92 | 2016 |
| Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes N Mavaddat, L Dorling, S Carvalho, J Allen, A Gonzalez-Neira, R Keeman, ... JAMA oncology 8 (3), e216744-e216744, 2022 | 82 | 2022 |
| Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study X Yang, M Eriksson, K Czene, A Lee, G Leslie, M Lush, J Wang, J Dennis, ... Journal of medical genetics 59 (12), 1196-1205, 2022 | 52 | 2022 |
| Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort J Li, WX Wen, M Eklund, A Kvist, M Eriksson, HN Christensen, ... International journal of cancer 144 (5), 1195-1204, 2019 | 49 | 2019 |
| Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial MB Mukesh, W Qian, JS Wilkinson, L Dorling, GC Barnett, AM Moody, ... Radiotherapy and Oncology 111 (2), 270-275, 2014 | 47 | 2014 |
| Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia WX Wen, J Allen, KN Lai, S Mariapun, SN Hasan, PS Ng, DSC Lee, ... Journal of medical genetics 55 (2), 97-103, 2018 | 45 | 2018 |
| A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related … JE Abraham, L Hiller, L Dorling, AL Vallier, J Dunn, S Bowden, S Ingle, ... BMC medicine 13, 1-9, 2015 | 38 | 2015 |
| Breast cancer risks associated with missense variants in breast cancer susceptibility genes L Dorling, S Carvalho, J Allen, MT Parsons, C Fortuno, A González-Neira, ... Genome medicine 14 (1), 51, 2022 | 35 | 2022 |
| Differential burden of rare and common variants on tumor characteristics, survival, and mode of detection in breast cancer J Li, E Ugalde-Morales, WX Wen, B Decker, M Eriksson, A Torstensson, ... Cancer Research 78 (21), 6329-6338, 2018 | 28 | 2018 |
| Patients with a high polygenic risk of breast cancer do not have an increased risk of radiotherapy toxicity L Dorling, GC Barnett, K Michailidou, CE Coles, NG Burnet, J Yarnold, ... Clinical Cancer Research 22 (6), 1413-1420, 2016 | 25 | 2016 |
| Splicing predictions, minigene analyses, and ACMG‐AMP clinical classification of 42 germline PALB2 splice‐site variants A Valenzuela‐Palomo, E Bueno‐Martínez, L Sanoguera‐Miralles, ... The Journal of Pathology 256 (3), 321-334, 2022 | 22 | 2022 |
| Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity M Ahmed, L Dorling, S Kerns, L Fachal, R Elliott, M Partliament, ... British Journal of Cancer 114 (10), 1165-1174, 2016 | 19 | 2016 |
